Matrix Metalloproteinase 7 Is Associated with Symptomatic Lesions and Adverse Events in Patients with Carotid Atherosclerosis (original) (raw)
Figure 6
Association between plasma levels of MMP-7 and adverse outcome in patients with carotid atherosclerosis.
Panel A shows Kaplan–Meier curve with the cumulative incidence of all-cause mortality during the entire study (mean follow-up 3.5 years) according to dichotomized MMP-7 levels (Cut-off median: 1.96 ng/mL). Panel B shows multi-variable analyses of predictors of all-cause mortality (direct entry). CRP and MMP-7 show expressed per SD change.